The 280E Paradox: How Moving to Schedule III Unlocks the IRS Offer in Compromise for Cannabis Businesses

For over four decades, state-licensed cannabis operators have faced a federal tax landscape that can only be described as punitive. While generating billions of dollars in legitimate revenue and operating under strict state regulatory frameworks, these businesses have been treated by the Internal Revenue Service (IRS) as illicit drug-trafficking enterprises. The mechanism behind this treatment is Internal Revenue Code (IRC) Section 280E, a relic of the 1980s drug war that disallows all standard business deductions for companies dealing in Schedule I or Schedule II controlled substances.

The financial weight of Section 280E has pushed countless dispensaries, cultivators, and manufacturers into severe federal tax debt. Historically, when an ordinary business falls behind on its taxes, the IRS offers a structural lifeline known as an Offer in Compromise (OIC)—a program authorized under IRC Section 7122 that allows qualifying taxpayers to settle their liabilities for a fraction of what they owe. But for cannabis companies, Section 280E acted as an invisible, insurmountable barrier to OIC approval.   

The landscape has fundamentally shifted. Following a series of executive directives, the Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) issued a historic Final Order reclassifying state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). This transition directly dismantles the structural barriers that previously blocked cannabis companies from accessing the OIC program.

To understand why an OIC was once structurally impossible—and how the shift to Schedule III suddenly makes it one of the most powerful tax resolution tools available—we must examine the underlying mechanics of IRS collection financial analysis, the concept of "phantom income," and the strict requirements of federal tax compliance.

The Historical Roadblock: Why 280E Made an OIC Impossible

To understand why the transition to Schedule III is so revolutionary, one must first understand how the IRS evaluates an Offer in Compromise and how Section 280E historically corrupted that evaluation.

When a taxpayer applies for an OIC based on Doubt as to Collectibility, the IRS does not look at the total tax bill and arbitrarily pick a lower number. Instead, the agency uses a strict, formulaic calculation detailed in Internal Revenue Manual (IRM) Section 5.8.5 to determine the taxpayer’s Reasonable Collection Potential (RCP). The RCP is the metric that dictates the minimum amount the IRS will accept to settle the debt.   

The formula for calculating RCP is straightforward:

RCP=Net Equity in Available Assets+Future Remaining Income (FRI)

Future Remaining Income represents the amount of money the IRS determines a business can afford to pay each month after accounting for its necessary operational expenses, multiplied by a factor of 12 or 24 months (depending on whether the taxpayer proposes a lump-sum cash offer or a periodic deferred payment offer).

The Phenomenon of "Phantom Income"

Under Schedule I, the calculation of Future Remaining Income for a cannabis business was completely divorced from economic reality. IRM guidelines mandated that IRS offer examiners apply Section 280E rules to the OIC financial analysis. This position was heavily litigated and ultimately solidified by the U.S. Tax Court in Mission Organic Center Inc. v. Commissioner, where the court affirmed that the IRS can legitimately disregard standard business expenses during collection evaluations if the business violates federal drug trafficking laws.   

When an IRS examiner evaluated a cannabis company’s income and expenses on Form 433-B (Collection Information Statement for Businesses), the examiner was legally required to cross out and disregard virtually every standard operational expense. Rent, payroll, marketing, utilities, insurance, and professional fees were completely eliminated from the calculation. Guided by foundational tax cases such as Californians Helping to Alleviate Medical Problems (CHAMP) v. Commissioner, the only expense the IRS was permitted to subtract from gross receipts was the Cost of Goods Sold (COGS).   

The mathematical result of this policy was the creation of massive "phantom income."

A Tale of Two Calculations: The Schedule I Disconnect

Consider a boutique medical marijuana dispensary generating $2,000,000 in annual gross revenue.

Cost of Goods Sold (COGS): $1,000,000

Operating Expenses (Rent, Payroll, Security, Utilities): $850,000

Actual Net Cash Flow: $150,000

In the real world, this business has $150,000 in cash left over to pay its taxes, reinvest, or handle debts.

However, under Schedule I rules, the IRS calculated the company's Future Remaining Income by ignoring the $850,000 in operating expenses. In the eyes of the IRS, the business had an annual disposable income of **$1,000,000** ($2,000,000 gross revenue minus $1,000,000 COGS).

If the IRS multiplied that phantom income over a standard 24-month collection period, the Future Remaining Income portion of the RCP formula alone would skyrocket to $2,000,000. If the dispensary owed $500,000 in back taxes, the IRS would look at the inflated RCP, conclude that the business had the "ability to pay" its tax bill four times over, and summarily reject the Offer in Compromise.

The business was caught in a cruel paradox: it was completely broke in terms of actual cash flow, yet it appeared extraordinarily wealthy on the IRS's financial evaluation sheets.

How Moving to Schedule III Corrects the RCP Formula

The rescheduling of state-licensed medical marijuana to Schedule III breaks this paradox completely. Because the text of Section 280E explicitly states that it only applies to substances listed on Schedule I or Schedule II, the reclassification means that Section 280E no longer applies to qualifying state-licensed medical cannabis operators.   

When a Schedule III cannabis business submits an Offer in Compromise, the IRS financial analysis must shift from the restrictive 280E framework to standard business valuation rules under IRC Section 162, which governs ordinary and necessary business expenses.

Step-by-Step Breakdown of the New Financial Analysis

Recognition of Actual Operating Expenses: When filling out Form 433-B, a cannabis business can now legitimately list its standard operating expenses—wages, rent, utilities, insurance, and advertising—as allowable cash outlays.   

Deflating the Future Remaining Income (FRI): Using the previous example, the IRS will no longer look at the dispensary as having $1,000,000 in available annual income. Instead, the examiner will subtract both the $1,000,000 in COGS and the $850,000 in ordinary operating expenses, arriving at the true economic net income of $150,000.

Aligning RCP with Reality: Over a 24-month payment structure, the FRI component of the Reasonable Collection Potential drops from an impossible $2,000,000 down to a realistic $300,000.

If that same business owes $500,000 in federal back taxes, its calculated RCP ($300,000) is now lower than the total liability. For the first time in history, the cannabis company can present a low-dollar settlement offer that aligns perfectly with its real-world economic capacity, and the IRS will have the legal authority to accept it.

Breaking the Cycle of Continuous Non-Compliance

An adjusted RCP formula is only half the battle. To secure an approved Offer in Compromise, a taxpayer must overcome another major hurdle: the strict requirement of future tax compliance.

Under IRM Section 5.8.1.1.3, the IRS will not compromise a tax liability with a business that is currently non-compliant or is expected to fall back into delinquency. The taxpayer must demonstrate that they have filed all required returns and possess the financial stability to timely file and pay their taxes for the next five consecutive years. If a business defaults on its current tax obligations during the OIC evaluation period or within five years after acceptance, the compromise is instantly revoked, and the original debt is reinstated with full penalties and interest.

Under Schedule I, satisfying this future compliance requirement was a statistical impossibility for the vast majority of cannabis operators.

The Compounding Debt Spiral

Because Section 280E stripped out standard business deductions, cannabis companies routinely faced effective federal tax rates ranging from 70% to 90% of their actual net income. This created a compounding cycle of debt:

[High Tax Burden (70-90%)] ➔ [Cash Flow Depletion] ➔ [Inability to Pay Current Taxes] ➔ [Accumulation of New Tax Debt] ➔ [OIC Rejection for Non-Compliance]

A business drowning in $500,000 of historical tax debt could not generate enough clean cash flow to pay its current, massively inflated quarterly estimated taxes while simultaneously trying to satisfy a settlement agreement. They were trapped in a perpetual loop of falling behind, making them permanently ineligible for an OIC.

The Schedule III Stabilization Effect

By moving to Schedule III, the prospective effective tax rate for state-licensed medical cannabis operators plummets back down to standard corporate (21%) or individual pass-through rates.

According to joint announcements from the U.S. Department of the Treasury and the IRS, upcoming administrative guidance is expected to implement a full-year transition rule. This means that for calendar-year taxpayers, Section 280E relief will apply as of January 1 of the rescheduling year, eliminating the need to divide expenses between pre- and post-rescheduling periods within the same tax year.   

This sudden, dramatic reduction in future tax liability provides immediate operational stabilization. The cash flow that was previously cannibalized by 280E tax payments is freed up. When applying for an OIC, the business can now confidently demonstrate to an IRS group manager that its ongoing revenues are more than sufficient to cover its normalized future tax obligations. The business becomes a viable candidate for a lasting, permanent settlement.   

The Strategic Window: Handling Legacy 280E Debt

A common point of confusion for business owners and tax practitioners is how the rescheduling affects debt that was accumulated prior to the Schedule III transition. It is critical to understand that the reclassification does not retroactively erase historical tax liabilities.

The IRS maintains that for the years a business operated while cannabis was classified under Schedule I, the tax liabilities calculated under Section 280E remain legally binding (as argued by the government in cases like New Mexico Top Organics, Inc. v. Commissioner). While the Final Order explicitly encourages the Treasury Department to provide retrospective relief, the current framework treats past 280E debt as a fixed, valid liability.

This is precisely where the Offer in Compromise becomes an invaluable strategic mechanism. The OIC is designed explicitly to settle legally binding tax liabilities that a taxpayer cannot afford to pay.   

The Power of the Statutory Levy Stay

The moment a cannabis company files a formally complete Offer in Compromise, a powerful statutory mechanism is triggered under IRC Section 6331(k). The IRS is legally prohibited from executing enforced collection actions—such as bank levies or asset seizures—while the offer is being reviewed by an examiner, while it is pending in IRS Appeals, or for 30 days following a rejection.

For a cannabis firm plagued by legacy 280E debt, this provides a vital strategic pause. Under Schedule I, the IRS could aggressively issue levies to collect on old debts. Filing an OIC stops the IRS collection machine in its tracks, giving the business the operational breathing room needed to leverage its new, improved Schedule III cash flow and negotiate a permanent settlement based on its true economic value.

Technical Nuances for Tax Practitioners and Operators

While the shift to Schedule III opens the door to the OIC program, navigating this transition requires a sophisticated understanding of tax law. This is not a blanket solution that applies universally or automatically.

1. The Medical vs. Recreational Split

The formal reclassification specifically applies to two distinct categories: FDA-approved cannabis products and marijuana products manufactured, distributed, or dispensed pursuant to a qualifying state-issued medical marijuana license. Adult-use or recreational cannabis, even if legal under state law, remains classified as a Schedule I controlled substance.   

For businesses operating in states with unified licenses or those that serve both medical patients and adult-use consumers, the IRS financial analysis will become highly complex. Tax practitioners must implement rigorous expense allocation and apportionment methodologies. Only the portion of the business's expenses attributable to the Schedule III medical operation can be used to reduce the Future Remaining Income calculation in an OIC.   

2. Entity Selection and Restructuring

The elimination of Section 280E for medical operators alters the math behind entity selection. Pass-through structures like S corporations and Partnerships become vastly more attractive, as they allow owners to utilize the Section 199A Qualified Business Income (QBI) deduction. When preparing a business for an OIC, restructuring the entity or filing protective refund claims under IRC Section 6511 for open tax years can dramatically shift the financial profile presented to the IRS.   

3. Timing the OIC Submission

To maximize the chances of OIC acceptance, a business must cleanly establish its new, lower-tax reality before submitting Form 656. Operators must work closely with specialized tax professionals to build a flawless record of interim compliance—ensuring federal tax deposits are made on time based on their new, normalized tax rates—before attempting to compromise legacy debt.

Conclusion: A New Era of Financial Recovery

The historical classification of cannabis under Schedule I turned the IRS into an inescapable financial equalizer, using Section 280E to drain the liquidity out of viable, state-compliant businesses. By inflating income on paper and triggering astronomical tax bills, the federal government effectively barred the cannabis industry from utilizing the very tax relief mechanisms guaranteed to ordinary American businesses.   

The migration of state-licensed medical marijuana to Schedule III changes the math entirely. By eliminating the artificial inflation of Reasonable Collection Potential and normalizing future tax burdens, this regulatory shift transforms the IRS Offer in Compromise from an impossible dream into an accessible, highly effective tool for corporate recovery. Legacy 280E debt no longer has to be a corporate death sentence.

Key Action Items for Distressed Cannabis Operators

Review Legacy Liabilities: Assess all outstanding federal tax debt from the Schedule I era to identify the exact scope of liabilities that need resolution.

Implement Strict Expense Apportionment: For multi-use facilities, establish clear accounting safeguards to isolate medical marijuana revenues and operating expenses from recreational operations.   

Establish Interim Compliance: Ensure all current federal tax deposits (FTDs) and estimated payments are meticulously maintained to fulfill the OIC's strict future-compliance mandates.

Consult with an Enrolled Agent or Tax Attorney: Work with an IRS representation specialist to model your company's new Schedule III Reasonable Collection Potential (RCP) before initiating contact with IRS Collections.

Sources

Section 280E Expenses Disallowed in Calculating Reasonable Collection Potential. - Parker Tax Publishing

www.parkertaxpublishing.com

IRS's rejection of marijuana dispensary's offer in compromise upheld - The Tax Adviser

www.thetaxadviser.com

Section 280E and the Offer-in-Compromise: A Technical Analysis of Mission Organic Center

www.currentfederaltaxdevelopments.com

Relief, Finally? DEA Issues Order Expediting Cannabis Rescheduling to Schedule III

www.duanemorris.com

From Schedule I to Schedule III: Tax and Estate Planning Consequences of Rescheduling State-Licensed Medical Marijuana - ESA Law

esapllc.com

Cannabis Rescheduling: DOJ Announces Rescheduling of Certain Products | Insights | Holland & Knight

www.hklaw.com

DOJ Officially Reschedules Certain Cannabis - Fox Rothschild LLP

www.foxrothschild.com

Featured Archives - Tax Attorney Orange County CA | Kahn Tax Law

www.kahntaxlaw.com

From Schedule I to III: A Partial Tax Reset for Cannabis Businesses - KMK Law

www.kmklaw.com

Cannabis Rescheduling: DOJ Announces Rescheduling of Certain Products | Insights | Holland & Knight

www.hklaw.com

DOJ Officially Reschedules Certain Cannabis - Fox Rothschild LLP

www.foxrothschild.com

From Schedule I to III: A Partial Tax Reset for Cannabis Businesses - KMK Law

www.kmklaw.com

DOJ Officially Reschedules Certain Cannabis - Fox Rothschild LLP

www.foxrothschild.com

#TaxResolution #EnrolledAgent #CannabisIndustry #TaxLaw #OfferInCompromise #IRC280E #CannabisAccounting #TaxPro